We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$22.1B
1-Year Est. Return
45.54%
This Fund
S&P 500
This Quarter
Est. Return
+9.33%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$13.9B
AUM Growth
+$700M
(+5.3%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
27.12%
Holding
2,867
New
34
Increased
533
Reduced
1,066
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$12.3M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$8.57M |
| 3 |
Vanguard World Funds Extended Duration ETF
EDV
|
+$7.05M |
| 4 |
GE HealthCare
GEHC
|
+$6.75M |
| 5 |
Aramark
ARMK
|
+$6.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$11.5M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$10.3M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$8.74M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$7.24M |
| 5 |
GE Aerospace
GE
|
+$7.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.35% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 10.88% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAT
1651
American Assets Trust
AAT
$1.39B
| $492K | ﹤0.01% |
26,466
| – | – |
|
1652
N-able
NABL
$695M
| $492K | ﹤0.01% |
37,268
| – | – |
|
1653
Astec Industries
ASTE
$994M
| $491K | ﹤0.01% |
11,909
-965
| -7% | -$40.7K |
|
1654
Arcus Biosciences
RCUS
$3.67B
| $491K | ﹤0.01% |
26,931
| – | – |
|
1655
Ecovyst
ECVT
$1.09B
| $491K | ﹤0.01% |
44,419
+8,096
| +22% | +$83.7K |
|
1656
LegalZoom.com
LZ
$930M
| $490K | ﹤0.01% |
52,285
| – | – |
|
1657
The GEO Group
GEO
$4B
| $489K | ﹤0.01% |
61,969
| – | – |
|
1658
AMERISAFE
AMSF
$504M
| $489K | ﹤0.01% |
9,986
-334
| -3% | -$17.5K |
|
1659
Geron
GERN
$982M
| $489K | ﹤0.01% |
225,163
+50,422
| +29% | +$143K |
|
1660
Adeia
ADEA
$3.16B
| $486K | ﹤0.01% |
54,813
| – | – |
|
1661
German American Bancorp
GABC
$1.92B
| $485K | ﹤0.01% |
14,537
| – | – |
|
1662
IMAX
IMAX
$2.81B
| $484K | ﹤0.01% |
25,248
-2,216
| -8% | -$38.1K |
|
1663
Winmark
WINA
$1.26B
| $484K | ﹤0.01% |
1,511
| – | – |
|
|
SWTX
1664
DELISTED
SpringWorks Therapeutics
SWTX
| $484K | ﹤0.01% |
18,797
+375
| +2% | +$11K |
|
|
BRKL
1665
DELISTED
Brookline Bancorp
BRKL
| $483K | ﹤0.01% |
46,045
+5,336
| +13% | +$67.2K |
|
|
FORG
1666
DELISTED
ForgeRock, Inc.
FORG
| $483K | ﹤0.01% |
23,469
+3,062
| +15% | +$62.2K |
|
1667
Rocket Pharmaceuticals
RCKT
$367M
| $483K | ﹤0.01% |
28,186
| – | – |
|
1668
Green Brick Partners
GRBK
$3.02B
| $482K | ﹤0.01% |
13,761
-1,169
| -8% | -$36.1K |
|
|
SPTN
1669
DELISTED
SpartanNash
SPTN
| $482K | ﹤0.01% |
19,416
| – | – |
|
1670
Recursion Pharmaceuticals
RXRX
$1.78B
| $481K | ﹤0.01% |
72,161
| – | – |
|
1671
AdaptHealth
AHCO
$760M
| $481K | ﹤0.01% |
38,693
| – | – |
|
1672
Virgin Galactic
SPCE
$475M
| $481K | ﹤0.01% |
5,935
-417
| -7% | -$41.6K |
|
1673
Iovance Biotherapeutics
IOVA
$2.95B
| $480K | ﹤0.01% |
78,571
| – | – |
|
1674
Unitil
UTL
$992M
| $480K | ﹤0.01% |
8,412
| – | – |
|
1675
Outset Medical
OM
$79.9M
| $480K | ﹤0.01% |
1,738
| – | – |
|
Similar funds
BA
FAM
VARA
CHP
MIC
OAG
MetLife Investment Management's Q1 2023 Portfolio in Review
As of Q1 2023, MetLife Investment Management held 2,867 positions worth $13.9B, up 5.3% from $13.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4%. MetLife Investment Management opened 34 new positions and exited 81, leaving the 2,867-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- MetLife Investment Management's largest Q1 2023 buy was Vanguard World Funds Extended Duration ETF: 79,420 shares worth $7.19M.
- MetLife Investment Management added most to iShares MSCI EAFE ETF in Q1 2023, an estimated $12.3M increase.
- MetLife Investment Management's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $11.5M.
- MetLife Investment Management fully exited iShares National Muni Bond ETF in Q1 2023, selling an estimated $10.3M.
- MetLife Investment Management's ten largest holdings make up 27% of its $13.9B portfolio in Q1 2023.
- MetLife Investment Management opened 34 new positions and closed 81 in Q1 2023.
- MetLife Investment Management's portfolio value rose 5.3% quarter-over-quarter to $13.9B.
Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.